140 related articles for article (PubMed ID: 3929420)
1. Danazol-induced factor VIII and IX bypassing activity in hemophiliacs.
Garewal HS; Corrigan JJ; Jeter MA; Damiano ML; Durie BG
Thromb Res; 1985 Jul; 39(1):117-25. PubMed ID: 3929420
[TBL] [Abstract][Full Text] [Related]
2. Effect of danazol on coagulation parameters and bleeding in hemophilia.
Garewal HS; Corrigan JJ; Durie BG; Jeter MA; Damiano ML
JAMA; 1985 Feb; 253(8):1154-6. PubMed ID: 3968845
[TBL] [Abstract][Full Text] [Related]
3. Danazol fails to increase factor VIII or IX levels in a double-blind crossover study of patients with haemophilia A and B.
Nugent DJ; Bray GL; Counts RB; Clements MJ; Thompson AR
Br J Haematol; 1986 Nov; 64(3):493-502. PubMed ID: 3098273
[TBL] [Abstract][Full Text] [Related]
4. Danazol therapy in haemophilia.
Heaton DC; Wyld PJ; Conder JL
N Z Med J; 1986 Mar; 99(798):185-7. PubMed ID: 3517712
[TBL] [Abstract][Full Text] [Related]
5. Danazol increases factor VIII and factor IX in classic hemophilia and Christmas disease.
Gralnick HR; Rick ME
N Engl J Med; 1983 Jun; 308(23):1393-5. PubMed ID: 6405274
[TBL] [Abstract][Full Text] [Related]
6. Benefits of danazol treatment in patients with hemophilia A (classic hemophilia).
Gralnick HR; Maisonneuve P; Sultan Y; Rick ME
JAMA; 1985 Feb; 253(8):1151-3. PubMed ID: 3918188
[TBL] [Abstract][Full Text] [Related]
7. Poor response to danazol in hemophilia.
Kasper CK; Boylen AL
Blood; 1985 Jan; 65(1):211-3. PubMed ID: 3917312
[TBL] [Abstract][Full Text] [Related]
8. Danazol in hemophilia.
Ambriz R; Pizzuto J; Guillen C
JAMA; 1985 Aug; 254(6):754-5. PubMed ID: 4009909
[No Abstract] [Full Text] [Related]
9. Danazol for severe disease.
Marwick C
JAMA; 1983 Jun; 249(24):3279, 3283. PubMed ID: 6854854
[No Abstract] [Full Text] [Related]
10. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies.
Lawrie AS; Kitchen S; Purdy G; Mackie IJ; Preston FE; Machin SJ
Clin Lab Haematol; 1998 Jun; 20(3):179-86. PubMed ID: 9681235
[TBL] [Abstract][Full Text] [Related]
11. Influence of factor VIII:C and factor IX activity in plasmas of haemophilic dogs on the activated partial thromboplastin time measured with two commercial reagents.
Mischke R
Haemophilia; 2000 May; 6(3):135-9. PubMed ID: 10792470
[TBL] [Abstract][Full Text] [Related]
12. Effect of danazol on clotting factor levels, bleeding incidence, factor infusion requirements, and immune parameters in hemophilia.
Saidi P; Lega BZ; Kim HC; Raska K
Blood; 1986 Sep; 68(3):673-9. PubMed ID: 3742049
[TBL] [Abstract][Full Text] [Related]
13. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
Welsch DJ; Novotny WF; Wun TC
Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340
[TBL] [Abstract][Full Text] [Related]
14. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity.
Negrier C; Goudemand J; Sultan Y; Bertrand M; Rothschild C; Lauroua P
Thromb Haemost; 1997 Jun; 77(6):1113-9. PubMed ID: 9241742
[TBL] [Abstract][Full Text] [Related]
15. Effect of stanozolol on factors VIII and IX and serum aminotransferases in haemophilia.
Greer IA; Greaves M; Madhok R; McLoughlin K; Porter N; Lowe GD; Preston FE; Forbes CD
Thromb Haemost; 1985 Jun; 53(3):386-9. PubMed ID: 3931287
[TBL] [Abstract][Full Text] [Related]
16. The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay.
Matsumoto T; Shima M; Takeyama M; Yoshida K; Tanaka I; Sakurai Y; Giles AR; Yoshioka A
J Thromb Haemost; 2006 Feb; 4(2):377-84. PubMed ID: 16420569
[TBL] [Abstract][Full Text] [Related]
17. Danazol and hemophilia.
Hathaway WE
JAMA; 1985 Feb; 253(8):1167. PubMed ID: 3968846
[No Abstract] [Full Text] [Related]
18. Exploiting sex for therapeutic purposes.
Gelfand JA
N Engl J Med; 1983 Jun; 308(23):1417-9. PubMed ID: 6682485
[No Abstract] [Full Text] [Related]
19. The prevalence of factor VIII and IX inhibitors among Saudi patients with hemophilia: Results from the Saudi national hemophilia screening program.
Owaidah T; Momen AA; Alzahrani H; Almusa A; Alkasim F; Tarawah A; Nouno RA; Batniji FA; Alothman F; Alomari A; Abu-Herbish S; Abu-Riash M; Siddiqui K; Ahmed M; Mohamed SY; Saleh M
Medicine (Baltimore); 2017 Jan; 96(2):e5456. PubMed ID: 28079788
[TBL] [Abstract][Full Text] [Related]
20. Targeting TFPI for hemophilia treatment.
Peterson JA; Maroney SA; Mast AE
Thromb Res; 2016 May; 141 Suppl 2(Suppl 2):S28-30. PubMed ID: 27207418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
